In what could represent a major advance in the fight against coronavirus, a Rutgers University research lab says it has developed a new test using existing automated technology able to analyze tens of thousands of patient samples each day to detect COVID-19. At the same time, RUCDR Infinite Biologics — a unit of Rutgers’ Human Genetics Institute of New Jersey — submitted an emergency use authorization request for a saliva collection method that would allow for far broader screening than what is now even possible. To read the full article.
Home / News / New coronavirus test developed at Rutgers can screen thousands and it’s as simple as a spit in a tube
Recent Posts
- NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
- Join The National Clinical Cohort Collaborative (N3C) Community Forum on 7/30
- NIH Fellowship Writing Group: Call for Applications – Sign Up by 8/25
- Rutgers Students Showcase AI-Driven Research Success Through NJ ACTS Summer Research Program
- Rutgers NJHealth Study Data Access Opportunity – Application Due July 6th!
Categories
- Community (2,500)
- Covid (1,001)
- CTO Events (6)
- News (3,174)
- Pilots (21)